Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.
Kramer
Judith M
JM
Duke Translational Medicine Institute, Duke University Medical Center, Durham, NC, USA.
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D026683:Advisory Committees; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations